| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 75,070 | 82,871 | 140,589 | | Cost of Revenue | 50,493 | 57,215 | 92,100 | | | Gross Profit | 24,577 | 25,656 | 48,489 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 30,767 | 34,921 | 45,418 | | Non Recurring | 10,831 | 6,485 | 22,960 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (17,021) | (15,750) | (19,889) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (17,021) | (15,750) | (19,889) | | Interest Expense | 1,613 | 1,402 | 5,968 | | Income Before Tax | (18,634) | (17,152) | (25,857) | | Income Tax Expense | 149 | (559) | (5,479) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,783) | (16,593) | (20,378) | | | Non-recurring Events | | Discontinued Operations | (677) | 15,249 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (19,460) | (1,344) | (20,378) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($19,460) | ($1,344) | ($20,378) |
|
1.48% Nasdaq 
0.01 (2.70%) 
Income Statement
